Wells Fargo’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.01M Sell
37,756
-5,980
-14% -$319K ﹤0.01% 2906
2025
Q1
$1.77M Sell
43,736
-18,131
-29% -$734K ﹤0.01% 2901
2024
Q4
$1.72M Buy
61,867
+7,587
+14% +$211K ﹤0.01% 2908
2024
Q3
$1.56M Buy
54,280
+24,829
+84% +$712K ﹤0.01% 2926
2024
Q2
$691K Buy
29,451
+9,325
+46% +$219K ﹤0.01% 3386
2024
Q1
$508K Buy
20,126
+5,763
+40% +$146K ﹤0.01% 3541
2023
Q4
$335K Sell
14,363
-31,243
-69% -$730K ﹤0.01% 3771
2023
Q3
$2.31M Sell
45,606
-2,845
-6% -$144K ﹤0.01% 2507
2023
Q2
$2.26M Buy
48,451
+11,834
+32% +$553K ﹤0.01% 2658
2023
Q1
$1.4M Buy
36,617
+34,800
+1,915% +$1.33M ﹤0.01% 2949
2022
Q4
$99.6K Buy
1,817
+82
+5% +$4.49K ﹤0.01% 4243
2022
Q3
$59K Sell
1,735
-67
-4% -$2.28K ﹤0.01% 4571
2022
Q2
$17K Sell
1,802
-2,286
-56% -$21.6K ﹤0.01% 5232
2022
Q1
$58K Sell
4,088
-8,862
-68% -$126K ﹤0.01% 5248
2021
Q4
$274K Buy
12,950
+12,473
+2,615% +$264K ﹤0.01% 4737
2021
Q3
$11K Buy
477
+250
+110% +$5.77K ﹤0.01% 5831
2021
Q2
$6K Sell
227
-150
-40% -$3.97K ﹤0.01% 5930
2021
Q1
$11K Sell
377
-29,645
-99% -$865K ﹤0.01% 5938
2020
Q4
$774K Buy
30,022
+23,629
+370% +$609K ﹤0.01% 4140
2020
Q3
$196K Sell
6,393
-14,941
-70% -$458K ﹤0.01% 4805
2020
Q2
$532K Buy
21,334
+15,189
+247% +$379K ﹤0.01% 4170
2020
Q1
$130K Buy
6,145
+2,981
+94% +$63.1K ﹤0.01% 4745
2019
Q4
$70K Buy
3,164
+2,778
+720% +$61.5K ﹤0.01% 5181
2019
Q3
$9K Buy
+386
New +$9K ﹤0.01% 5554